AzTrials
AzTrials

Acute Respiratory Distress SyndromeNCT06477861

The Role of Elastic Power in Predicting the Severity and Mortality in Adult Patients With ARDS Due to Pneumonia

An observational study of Acute Respiratory Distress Syndrome, run by Benha University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

the role of elastic power in the prediction of severity and mortality in adults with ARDS secondary to pneumonia Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Acute Respiratory Distress Syndrome
What is being tested?
calculation of the elastic power of the lung in case of the ARDS and corolating with the severity index of Berline definition of ARDS in respect to mortality and severity
How many people
70 participants
Where
1 siteEgypt
Study dates
24 Jan 2024to 24 Oct 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: It's the population from which sample size will be non randomly selected. The study will be on ARDS patients who will be admitted to ICU of Benha University hospitals . a) Sample size : The sample size was calculated using G*power software based on a previous study by Xie , who investigated the elastic power as a predictor of ARDS severity. They reported a large effect size of elastic power between mild to moderate and moderate to severe ARDS patients. The minimum sample size needed to detect a large effect size (d = 0.8) between such groups is 70 patients (at least 20 with mild to moderate disease and 50 with severe disease). Alpha and power levels were adjusted at 0.05 and 0.8, respectively

Who may be able to join

  • Age from 18 to 65 years (male or female). Patients fulfilling criteria of ARDS as per Berline definition who will be admitted to ICU , intubated and MV more than 48 hours will be included in this study.
  • Fulfillment of Criteria of readiness for ARDS as per Berline definition :
  • an acute onset (<1 week of a known clinical insult or new or worsening respiratory symptoms),
  • respiratory failure not primarily due to hydrostatic edema,
  • bilateral opacities on a chest radiograph (not fully explained by effusions, lobar or lung collapse, or nodules), and
  • <300 mmHg of the ratio of arterial partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2) (PaO2/FiO2) with 5 cm H2O of positive end-expiratory pressure (PEEP) or continuous positive airway pressure. To facilitate the estimation of the ARDS prognosis, the Berline definition classifies the severity of ARDS into 3 categories: mild (200 mmHg < PaO2/FiO2 < 300 mmHg), moderate (100 mm Hg < PaO2/FiO2 <200 mmHg), and severe (PaO2/FiO2 < 100 mmHg).

Who cannot join

  • Non intubated ICU admissions
  • Non-invasive ventilated patients.
  • Age less than 18 years or more than 65 years of age
  • Open chest wall trauma.
  • Patient requiring Extra Corporal Membrane Oxygenator
  • Patients with increased intrabdominal pressure interfering with mechanical ventilator parameters measurements

Trial locations and contacts

1 site in 1 country.

Ahmed H Awad, MsC.ICU contact

+971561707026

ahmedhossam79@gmail.com

Samar R Mohamed contact

01287793991

Egypt1 site, 1 recruiting
  • Banha University Hospital

    Banhā, Al Qalubeyah

    Samar R Mohammed, lecturer, +201287793991

    Samar R Mohamed, 01287793991

    Recruiting

Other trials in Egypt

About this study

Official title: The Role of Elastic Power in Predicting the Severity and Mortality in Adult Patients With Acute Respiratory Distress Syndrome Secondary to Pneumonia

the role of elastic power in the prediction of severity and mortality in adults with ARDS secondary to pneumonia

Read the detailed description

Acute respiratory distress syndrome (ARDS) is an acute inflammatory pulmonary disease due to an acute damage of the alveoli, being the most common acute and critical illnesses in intensive critical care medicine.

The international epidemiological LUNGSAFE study shows that the incidence of ARDS in the ICU is approximately 10%, and the mortality rate is still as high as 30-50%, representing a major medical problem facing the society at present .

The Berlin criteria underwent a significant improvement in 2012, and the severity of the disease is graded according to the oxygenation index as compared with the previous ARDS American-European Consensus Conference (AECC) definition .

However, the further research on ARDS in the past ten years revealed that the Berlin standard also has some limitations .

First, investigations found that early oxygenation index (PaO2/FiO2 ratio) may not fully reflect the severity of lung disease in ARDS patients due to the different phases of ARDS progression and the distinctive responses to oxygenation strategy in diseased lung tissues.

Indeed, the disease stratification according to the early PaO2/FiO2 ratio is not effective in predicting the prognosis of patients.

Lung protective ventilation in ARDS involves a variety of respiratory mechanics, such as tidal volume, driving pressure, lung compliance, flow rate, positive end expiratory pressure (PEEP), and respiratory rate.

However, each mechanical parameter alone is too one-sided to reflect the pathogenic factors of ventilator induced lung injury (ventilator induced lung injury) and evaluate the severity of ARDS. Thus, Gattinoni in 2016 introduced the concept of mechanical power (MP) as the power exerted by the ventilator to the entire respiratory system in one minute during mechanical ventilation.

Therefore, MP is a new concept in mechanical ventilation that is being increasingly recognized and studied in the field of critical care medicine. MP consists of three parts :the energy delivered just once when PEEP is applied, the energy applied to overcome airway resistance and finally, the elastic energy delivered at each tidal breath.

Nevertheless, shortcomings also exist in the assessment and quantification of ventilator induced lung injury (VILI) and the degree of lung injury by MP. For example, the energy consumed by the airflow to overcome airway resistance is difficult to link with the alveolar damage, and the energy carried by the airflow itself does not necessarily lead to ventilator induced lung injury (VILI). Airway resistance and peak airway pressure are not significantly associated with VILI, as highlighted by classic lung protective ventilation strategies.

The combined effect of plateau pressure, driving pressure, tidal volume, and changes in lung compliance are the parameters for the prevention of VILI. Among the components of MP, the most closely related to ARDS lung injury might be elastic power (i.e., the power to overcome the elastic resistance of the respiratory system). Elastic energy refers to the energy exerted by the ventilator to overcome the elastic resistance of the respiratory system with a single ventilation and elastic power (EP) is the power exerted by the ventilator to overcome the elastic resistance of the respiratory system in one minute. The EP is comprised of two elements: the energy required to surpass the baseline stretch of the fibers and the energy necessary to overcome the elasticity of the respiratory system with every delivery of tidal volume.

Being tested
calculation of the elastic power of the lung in case of the ARDS and corolating with the severity index of Berline definition of ARDS in respect to mortality and severity
Medical subject headings
Respiratory Distress Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • calculation of the elastic power of the lung in case of the ARDS and corolating with the severity index of Berline definition of ARDS in respect to mortality and severityOther

    calculation of variables of the elastic power of the lung from the lung pressures on the ventilator : Elastic power = 0.098 * tidal volume * respiratory rate * 1/2(PEEP+Pplat)

Study groups in NCT06477861
Study groupRoleWhat they receive
mild to moderate ARDS100 =< PO2/FiO2 ratio < 300
Receives: Other: calculation of the elastic power of the lung in case of the ARDS and corolating with the severity index of Berline definition of ARDS in respect to mortality and severity
severe ARDS100 < PO2/FiO2 ratio
Receives: Other: calculation of the elastic power of the lung in case of the ARDS and corolating with the severity index of Berline definition of ARDS in respect to mortality and severity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 28 day mortality

    • survivors are defined as patients who are discharged from ICU or survive beyond 28 days

    Measured: 28 days

Secondary outcomes (1)
  1. elastic power normalized to compliance

    investigators will compare the results of the elastic power and the elastic power normalized to compliance with the current criteria of Berlin definition of the severity of ARDS depending on the PO2/FiO2 ratio and the expected mortality to determine which is more accurate in prediction of severity and mortality. Investigators will compare the predicted values of Berline definition in regards to mortality with the values obtained from the elastic power and the elastic power corrected to compliance equations to investigate which was more reliable and accurate.

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2024
  2. Study start24 Jan 2024
  3. Primary completion24 Sep 2024 (estimated)
  4. Study completion24 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06477861
Sponsor's protocol ID
MD.11.12.2023
Status last verified
Jun 2024
First submitted
5 Jun 2024
Last updated
27 Jun 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Respiratory Distress Syndrome, run by Benha University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed H Awad, MsC.ICU (+971561707026, ahmedhossam79@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

28 day mortality (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in